PassPort Technologies

Pass Port Technologies

Pharmaceuticals, 5580 Morehouse Dr, San Diego, California, 92121, United States, 1-10 Employees

passport-tech.com

  • twitter
  • LinkedIn

phone no Phone Number: +18*********

Who is PASSPORT TECHNOLOGIES

After a technology spin-out from Nitto Denko Corporation (Japans leading diversified materials manufacturer), PassPort Technologies was established in San Diego, California, to continue R...

Read More

map
  • 5580 Morehouse Dr, San Diego, California, 92121, United States Headquarters: 5580 Morehouse Dr, San Diego, California, 92121, United States
  • 2019 Date Founded: 2019
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 7629

checked-icon Does something look wrong? Fix it. | View contact records from PASSPORT TECHNOLOGIES

PassPort Technologies Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PassPort Technologies

Answer: PassPort Technologies's headquarters are located at 5580 Morehouse Dr, San Diego, California, 92121, United States

Answer: PassPort Technologies's phone number is +18*********

Answer: PassPort Technologies's official website is https://passport-tech.com

Answer: PassPort Technologies's revenue is Under $1 Million

Answer: PassPort Technologies's SIC: 7629

Answer: PassPort Technologies has 1-10 employees

Answer: PassPort Technologies is in Pharmaceuticals

Answer: PassPort Technologies contact info: Phone number: +18********* Website: https://passport-tech.com

Answer: After a technology spin-out from Nitto Denko Corporation (Japans leading diversified materials manufacturer), PassPort Technologies was established in San Diego, California, to continue R&D efforts towards the commercialization of improved pharmaceutical products using its patent-protected transdermal drug delivery platform (PassPort System). The result is a unique drug repositioning opportunity for companies who already offer approved therapeutics, as well as those developing new NCE candidates that could benefit from alternative/improved routes of administration. The novel PassPort System combines microporation technology to painlessly create micropores on the skin surface and patch formulation technology that controls drug absorption through the micropores. By using the PassPort System, it is now possible for transdermal needle-free administration of drugs that have previously been limited to injections or infusions. This platform is not only applicable to low molecular weight drugs but also for other modalities such as peptides, oligonucleotides and proteins.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access